Abraham Bassan's most recent trade in Septerna Inc. was a trade of 15,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 26, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Septerna Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2026 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2026 | 123,600 | 123,600 | - | - | Director Stock Option (Right to Buy) | |
| Rani Therapeutics Holdings Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Oct 2025 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Abraham Bassan | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 19 Aug 2025 | 25,000 | 0 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2025 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Septerna Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2025 | 16,623 | 16,623 | - | - | Stock Option (Right to Buy) | |
| CARGO Therapeutics Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2024 | 23,742 | 23,742 | - | - | Stock Option (Right to Buy) | |
| Graphite Bio Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 Jul 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Graphite Bio Inc | Abraham Bassan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |